title: Commentary: the pedunculopontine nucleus: clinical experience, basic questions and future directions.
abstract: This issue is dedicated to a potential new target for the treatment of movement disorders, the pedunculopontine tegmental nucleus (PPTg), or, more simply, the pedunculopontine nucleus, that some authors abbreviate as PPN. We provide an overview of the field as an introduction to the general reader, beginning with the clinical experience to date of Mazzone and co-workers in Rome, some basic questions that need to be addressed, and potential future directions required in order to ensure that the potential benefits of this work are realized.
authors.forename: P
authors.initials: P
authors.lastname: Mazzone
authors.forename: E
authors.initials: E
authors.lastname: Scarnati
authors.forename: E
authors.initials: E
authors.lastname: Garcia-Rill
mesh_terms: D046690:Deep Brain Stimulation / Q000379:methods* / Q000639:trends*; D006801:Humans; D010300:Parkinson Disease / Q000628:therapy*; D045042:Pedunculopontine Tegmental Nucleus / Q000502:physiology*